Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renin Hypertension”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Large-scale testing (Phase 3)UnknownNCT00225667
What this trial is testing

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

Who this might be right for
Atrial FibrillationHypertension
Connolly, Stuart, M.D. 200
Early research (Phase 1)WithdrawnNCT01432106
What this trial is testing

The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic Syndrome

Who this might be right for
HypertensionMetabolic Syndrome
University of Michigan
Post-approval studies (Phase 4)Ended earlyNCT00974922
What this trial is testing

Vitamin D Deficiency in Patients With Hypertension

Who this might be right for
Vitamin D DeficiencyHypertension
UConn Health 40
Post-approval studies (Phase 4)Looking for participantsNCT06256991
What this trial is testing

Potassium Correction for RAAS Optimization in Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseasesHyperkalemiaHypertension
University Medical Center Groningen 44
Testing effectiveness (Phase 2)Study completedNCT00834041
What this trial is testing

Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

Who this might be right for
Hypertension
Novartis 39
Post-approval studies (Phase 4)UnknownNCT00517322
What this trial is testing

Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan

Who this might be right for
Left Atrial VolumeHypertensive Heart DiseaseAntihypertensive Drugs+2 more
Università degli Studi dell'Insubria 80
Not applicableStudy completedNCT04991961
What this trial is testing

Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Primary Aldosteronism

Who this might be right for
HypertensionPrimary Aldosteronism
Chongqing Medical University 341
Post-approval studies (Phase 4)UnknownNCT02351973
What this trial is testing

Comparison of Single and Combination Diuretics in Low-Renin Hypertension

Who this might be right for
Hypertension
University of Cambridge 423
Large-scale testing (Phase 3)Study completedNCT01885559
What this trial is testing

HALT Progression of Polycystic Kidney Disease Study B

Who this might be right for
Kidney, Polycystic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 486
Very early researchEnded earlyNCT00585442
What this trial is testing

Effects of Vitamin D on Renin Expression in Hypertensive Patients

Who this might be right for
HypertensionVitamin D Deficiency
University of Utah 12
Not applicableStudy completedNCT06764277
What this trial is testing

Mechanisms and Phenotypes of Hypertension in Patients in Chronic Hemodialysis

Who this might be right for
Arterial HypertensionHemodialysis
Bernardo Rodríguez Iturbe 32
Post-approval studies (Phase 4)Study completedNCT00921570
What this trial is testing

The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With Hypertension

Who this might be right for
DiabetesHypertensionProteinuria
Gulhane School of Medicine 105
Not applicableActive Not RecruitingNCT03292094
What this trial is testing

The African-PREDICT Study

Who this might be right for
Cardiovascular DiseasesHypertensionHealth Risk Behaviors+3 more
North-West University, South Africa 1,202
Post-approval studies (Phase 4)Study completedNCT01328769
What this trial is testing

Febuxostat, Blood Pressure and the Intrarenal Renin-Angiotensin System (RAS)

Who this might be right for
Hypertension
Paul N. Hopkins 49
Not applicableStudy completedNCT01173029
What this trial is testing

Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events

Who this might be right for
Systemic Arterial HypertensionHypertension Resistant to Conventional TherapyMyocardial Infarction+1 more
Universidade Gama Filho 92
Post-approval studies (Phase 4)WithdrawnNCT01409408
What this trial is testing

Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan

Who this might be right for
HypertensionDiabetes Mellitus
Hospital Universitario Pedro Ernesto
Not applicableUnknownNCT04374110
What this trial is testing

Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19

Who this might be right for
COVIDHypertensionCardiovascular Diseases+1 more
National Institute of Cardiology, Warsaw, Poland 1,000
Not applicableUnknownNCT00429897
What this trial is testing

Double Blind Crossover Comparison of Diuretics in the Young

Who this might be right for
Low-Renin Hypertension
University of Cambridge 30
Not applicableStudy completedNCT01071681
What this trial is testing

Survey to Assess Why People Are Not Responding to Treatment in Hypertension

Who this might be right for
Arterial Hypertension
Bayer 1,589
Testing effectiveness (Phase 2)Study completedNCT03756103
What this trial is testing

Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients

Who this might be right for
Hypertension,Essential
Shanghai Pharmaceuticals Holding Co., Ltd 120
Load More Results